GLUT3 is also overexpressed in several cancers, and its upregulation correlates with poor survival and tumor aggressiveness in brain32,33, lung34,35, laryngeal36, breast37, gastric38, liver39, and colorectal40 cancers. The gene discussed is SLC2A3; the disease is cancer.